OptimizeRx (OPRX) Non Operating Income (2014 - 2026)

OptimizeRx has disclosed Non Operating Income across 10 years of filings, most recently posting -$1.0 million for Q2 2026.

• In Q2 2026, Non Operating Income rose 31.71% year-over-year to -$1.0 million; the TTM figure through Jun 2026 stood at -$4.1 million (up 23.92% YoY), while the FY2025 annual figure was -$4.7 million, up 16.48% from the prior year.
• Non Operating Income came in at -$1.0 million for Q2 2026 at OptimizeRx, up from -$1.0 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $721000.0 in Q2 2023 to a low of -$1.5 million in Q1 2024.
• Average Non Operating Income over 4 years is -$802357.1, with a median of -$1.1 million recorded in 2025.
• Year-over-year, Non Operating Income tumbled 329.47% in 2024 and soared 31.71% in 2026.
• Over 4 years, Non Operating Income stood at -$836000.0 in 2023, then sank by 70.57% to -$1.4 million in 2024, then climbed by 23.0% to -$1.1 million in 2025, then rose by 8.2% to -$1.0 million in 2026.
• Per Business Quant data, the three most recent Non Operating Income figures were -$1.0 million in Q2 2026, -$1.0 million in Q1 2026, and -$1.1 million in Q4 2025.